Date of approval | Product/manufacturer | Material | Indications |
---|---|---|---|
|
Restylane Kysse / Galderma Laboratories, LP | 20 mg/ml; HA, 0.3% lidocaine | lip augmentation, lip wrinkles |
|
Juvéderm Volbella XC / Allergan, Inc | 15 mg/ml; HA, 0.3% lidocaine | lip augmentation, lip wrinkles |
|
Juvéderm Ultra XC / Allergan, Inc | 24 mg/ml; HA, 0.3% lidocaine | lip augmentation, lip wrinkles |
|
Restylane Silk / Galderma Laboratories, LP | 20 mg/ml; HA, 0.3% lidocaine | lip augmentation, lip wrinkles |
|
Restylane-L / Galderma Laboratories, LP | 20 mg/ml; HA, 0.3% lidocaine | lip augmentation, lip wrinkles |
|
Belotero Balance / Merz Aesthetics | 22.5 mg/ml; HA | lip wrinkles |
|
Restylane / Galderma Laboratories, LP | 20 mg/ml; HA | lip augmentation, lip wrinkles |
No. | Age at complication | Lump site | Filler type | Time to complication (years from procedure) | Clinical diagnosis | Ultrasound diagnosis |
---|---|---|---|---|---|---|
1. | 38 | upper lip | unknown | 12 | nodules or granulomas | massive fibrosis, labial glands |
2. | 40 | lower lip | HA a few times | 5 | nodules or granulomas | massive fibrosis, labial glands catching on the incisors |
3. | 28 | lower lip, upper lip | HA a few times | 4 | nodules or granulomas | persistent deposits, labial glands |
4. | 43 | upper lip, lower lip | PA A G | 12 | nodules or granulomas | granulomas, persistent deposits, labial glands |
5. | 38 | upper lip, lower lip | HA twice | 1 | nodules or granulomas | deposits, granulomas, labial glands |